Day, Emily A.
Ford, Rebecca J.
Smith, Brennan K.
Mohammadi-Shemirani, Pedrum
Morrow, Marisa R.
Gutgesell, Robert M.
Lu, Rachel
Raphenya, Amogelang R. http://orcid.org/0000-0001-9259-5280
Kabiri, Mostafa
McArthur, Andrew G.
McInnes, Natalia
Hess, Sibylle
Paré, Guillaume
Gerstein, Hertzel C.
Steinberg, Gregory R. http://orcid.org/0000-0001-5425-8275
Funding for this research was provided by:
Gouvernement du Canada | Canadian Institutes of Health Research (201709FDN-CEBA-116200 to GS)
Diabetes Canada (DI-5-17-5302-GS)
Article History
Received: 26 June 2019
Accepted: 6 November 2019
First Online: 9 December 2019
Competing interests
: S.H., G.P., H.C.G. and G.R.S. hold a patent entitled ‘Growth differentiation factor 15 as biomarker for metformin’ (WO/2017/108941). S.H. and M.K. are employees of Sanofi. All other authors have no competing interests.